A Phase 1 Study of GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Clinical trial NCT07181369 · RECRUITING

Trial details

NCT number: NCT07181369
Sponsor: Granular Therapeutics Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects Cold Urticaria Symptomatic Dermographism Chronic Inducible Urticaria

Start date: 2025-10-06
Primary completion: 2027-08-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.